About Us
Our Partnership
Key Structures
Engage With Us
Topics
Replenishment
Our Financing
Results & Data
Impact Stories
-
19 March 2024Chest Camps in Pakistan Bring TB Services to the People
-
06 March 2024Women at the Forefront: Providing Vital Care to Communities Caught in Crises
-
01 March 2024In Côte d’Ivoire, Transgender Communities Break Down Barriers in the Fight Against HIV
-
15 February 2024In Syria, People Can Breathe with New Supply of Medical Oxygen
Media Resources
News Releases
Opinion
Publication Categories
Resources
GF/B37/DP12
Approved by the Board on: 04 May 2017
Amended and Restated Global Fund Quality Assurance Policy for Diagnostic Products
Based on the recommendation of the Strategy Committee, the Board approves the amended and restated Global Fund Quality Assurance Policy for Diagnostic Products, as set forth in Annex 1 to GF/B37/06.
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website. To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.